Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden

Table 3 Model probabilities of exacerbations by GOLD states

GOLD	Usual care			Tiotropium			Glycopyrronium
GOLD	II	III	IV	II	III	IV	II	III	IV
No exacerbation	0.84	0.78	0.73	0.87	0.81	0.77	0.86	0.79	0.74
Non-severe exacerbation	0.14	0.17	0.18	0.11	0.14	0.15	0.11	0.14	0.14
Severe exacerbation	0.02	0.05	0.08	0.02	0.05	0.08	0.03	0.07	0.12

Source: [28] (derived from [17]), [20] and own calculations to reflect three month probabilities

ISSN: 1478-7547